Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

NICE issues final draft guidance recommending selective dapagliflozin use

May 31, 2013

FDA grants breakthrough therapy designation to Alexion's asfotase alfa

May 29, 2013

In vivo results for a novel ApoC-II mimetic peptide reported

May 28, 2013

Headline results reported from phase IIIa trial of liraglutide for obesity

May 27, 2013

Mitsubishi Tanabe Pharma seeks Japanese approval of canagliflozin

May 27, 2013

Novel FABP inhibitors divulged by Roche

May 27, 2013

Merck & Co. patents novel GPR119 receptor agonists

May 27, 2013

New inhibitors of phosphate transport synthesized by Astellas

May 27, 2013

HGT-1410 demonstrates rapid systemic distribution in vivo

May 27, 2013

University of Tromso and Biosortia Pharmaceuticals enter collaboration

May 24, 2013

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...